Since the first description of natural killer (NK) cells, the view on their role in innate immunity has evolved considerably. In addition to first-line defense against transformed and pathogen-infected autologous cells, NK cells contribute to modulate adaptive immune responses and in some cases acquire specialized functions, including...
-
2017 (v1)PublicationUploaded on: April 14, 2023
-
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2015 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2015 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
Background: In recent years, Highly-Active Anti-Retroviral Therapies (HAARTs) have modified the Human Immunodeficiency Virus (HIV) life-cycle and the disease is now considered chronic. Consequently, a longitudinal and complex follow-up is now required for HIV positive patients during their lifetime. Moreover, patients often encounter various...
Uploaded on: April 14, 2023 -
2013 (v1)Publication
Scopo dello studio: valutare la durability, la safety e il recupero immunologico in una coorte di pazienti (pz) HIV positivi (+) in terapia con Maraviroc (MVC) Metodi: Sono stati analizzati i dati di pz HIV + in terapia antiretrovirale (ART) contenente MVC almeno da 6 mesi (tutti con virus CCR-5 tropico secondo l'analisi genotipica e...
Uploaded on: April 14, 2023 -
2014 (v1)Publication
INTRODUCTION: The persistence of immune activation and inflammation in HIV patients with HIV-RNA (VL) undetectable causes many co-morbidities [1-3]. The aim of this study is to correlate monocytes (m) and NK cell activation levels, soluble markers and oxidative stress with clinical, biochemical and metabolic data in HIV-1 infected patients...
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2012 (v1)Publication
Purpose of the study: Promising research suggest that maraviroc (MVC) has favourable clinical outcome in HIV-infected patients (pts). Aim of the study is to assess: durability, safety profile and immunovirological recovery in a large MVC-based cohort. Methods: All HIV pts treated with antiretroviral therapy (ART) containing MVC for at least 6...
Uploaded on: April 14, 2023